Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...
When Lauren and Joe Sewell welcomed their daughter Violette, they immediately suspected something was wrong, but doctors ...
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...
Liver cancer is the fourth most common cancer in Malaysia and the fourth leading cause of cancer-related deaths, with 1,700 ...
News Medical on MSN3d
Novel therapeutic approaches targeting the Wnt pathway in hepatocellular carcinomaHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.
Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...
SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback